AMDOCS LIMITED (DOX) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2024-09-30..
- Stock-based compensation / revenue · 12 months: Value 2.09%; Formula and calculation Share-based compensation / revenue. Period ending 2024-09-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2024-09-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2024-09-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 2.09% | Share-based compensation / revenue. Period ending 2024-09-30. $104.54M ÷ $5.00B × 100 ≈ 2.09% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 5.00B USD | |
| Stock-based compensation | 104.54M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 628.61M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | (m) | $5.00B | $104.54M | $628.61M | (m) | (m) | 2.09% | (m) | (m) |
| 2024-06-30 | (m) | $4.98B | (m) | $654.86M | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | $4.97B | (m) | $661.71M | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | $4.95B | (m) | $688.25M | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | (m) | $4.89B | $89.70M | $653.99M | $23.09M | (m) | 1.84% | 28.32× | Reported |
| 2023-06-30 | (m) | $4.81B | (m) | $686.75M | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | $4.74B | (m) | $673.35M | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | $4.66B | (m) | $654.73M | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | (m) | $4.58B | $71.81M | $664.80M | $16.91M | (m) | 1.57% | 39.31× | Reported |
| 2022-06-30 | (m) | $4.50B | (m) | $647.44M | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | $4.40B | (m) | $633.05M | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | $4.31B | (m) | $618.64M | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | $4.29B | $54.25M | $598.69M | $21.27M | (m) | 1.26% | 28.14× | Reported |
| 2021-06-30 | (m) | $4.25B | (m) | $591.30M | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | $4.21B | (m) | $583.91M | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | $4.21B | (m) | $591.38M | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | (m) | $4.17B | $42.43M | $594.76M | $10.43M | (m) | 1.02% | 57.04× | Reported |
| 2020-06-30 | (m) | $4.15B | (m) | $591.97M | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | $4.14B | (m) | $586.76M | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | $4.12B | (m) | $580.23M | (m) | (m) | (m) | (m) | (m) |
| 2019-09-30 | (m) | $4.09B | $38.55M | $569.75M | $3.91M | (m) | 0.94% | 145.68× | Reported |
| 2019-06-30 | (m) | $4.06B | (m) | $494.41M | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | (m) | $4.04B | (m) | $457.61M | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | $4.01B | (m) | $439.26M | (m) | (m) | (m) | (m) | (m) |
| 2018-09-30 | (m) | $3.97B | $47.48M | $428.31M | $2.76M | (m) | 1.19% | 154.96× | Reported |
| 2018-06-30 | (m) | $3.95B | (m) | $491.54M | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | $3.92B | (m) | $515.93M | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | $3.89B | (m) | $517.88M | (m) | (m) | (m) | (m) | (m) |
| 2017-09-30 | (m) | $3.87B | $44.54M | $517.33M | $1.60M | (m) | 1.15% | 323.33× | Reported |
| 2017-06-30 | (m) | $3.83B | (m) | $503.78M | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | $3.79B | (m) | $498.83M | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | (m) | $3.75B | (m) | $485.20M | (m) | (m) | (m) | (m) | (m) |
| 2016-09-30 | (m) | $3.72B | $42.70M | $483.14M | $1.67M | (m) | 1.15% | 289.83× | Reported |
| 2016-06-30 | (m) | $3.70B | (m) | $474.34M | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | (m) | $3.68B | (m) | $476.11M | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | $3.66B | (m) | $493.96M | (m) | (m) | (m) | (m) | (m) |
| 2015-09-30 | (m) | $3.64B | $44.56M | $515.95M | $3.14M | (m) | 1.22% | 164.21× | Reported |
| 2015-06-30 | (m) | $3.62B | (m) | $532.36M | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | $3.61B | (m) | $530.63M | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | $3.61B | (m) | $516.48M | (m) | (m) | (m) | (m) | (m) |
| 2014-09-30 | (m) | (m) | $44.58M | $495.65M | $3.48M | (m) | (m) | 142.30× | Reported |
| 2014-06-30 | (m) | (m) | (m) | $492.42M | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | (m) | (m) | (m) | $490.58M | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | (m) | (m) | (m) | $489.58M | (m) | (m) | (m) | (m) | (m) |
| 2013-09-30 | (m) | (m) | $40.34M | $481.55M | $3.56M | (m) | (m) | 135.38× | Reported |
| 2013-06-30 | (m) | (m) | (m) | $472.18M | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | (m) | (m) | (m) | $459.06M | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | (m) | (m) | $446.08M | (m) | (m) | (m) | (m) | (m) |
| 2012-09-30 | (m) | (m) | $43.43M | $442.47M | $3.17M | (m) | (m) | 139.36× | Reported |
| 2012-06-30 | (m) | (m) | (m) | $433.52M | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | (m) | (m) | (m) | $429.14M | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | (m) | (m) | $425.83M | (m) | (m) | (m) | (m) | (m) |
| 2011-09-30 | (m) | (m) | $36.63M | $404.36M | $-2.88M | (m) | (m) | (m) | Reported |
| 2011-06-30 | (m) | (m) | (m) | $402.70M | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | $402.30M | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | (m) | (m) | $398.87M | (m) | (m) | (m) | (m) | (m) |
| 2010-09-30 | (m) | (m) | $44.45M | $410.43M | $3.13M | (m) | (m) | 130.92× | Reported |
| 2010-06-30 | (m) | (m) | (m) | $404.39M | (m) | (m) | (m) | (m) | (m) |
| 2010-03-31 | (m) | (m) | (m) | $392.37M | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | (m) | (m) | $385.20M | (m) | (m) | (m) | (m) | (m) |
| 2009-09-30 | (m) | (m) | $42.91M | $367.32M | (m) | (m) | (m) | (m) | (m) |
| 2009-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-09-30 | (m) | (m) | $57.49M | $405.60M | (m) | (m) | (m) | (m) | (m) |
| 2007-09-30 | (m) | (m) | $53.59M | $357.43M | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.